LifeMD (LFMD) Competitors

LifeMD (NASDAQ:LFMD) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation, dividends and community ranking.

Does the MarketBeat Community favor LFMD or PNTG?

The Pennant Group received 3 more outperform votes than LifeMD when rated by MarketBeat users. However, 76.47% of users gave LifeMD an outperform vote while only 46.67% of users gave The Pennant Group an outperform vote.

Company	Underperform	Outperform
LifeMD	Outperform Votes 39 76.47%	Underperform Votes 12 23.53%
The Pennant Group	Outperform Votes 42 46.67%	Underperform Votes 48 53.33%

Which has higher earnings & valuation, LFMD or PNTG?

The Pennant Group has higher revenue and earnings than LifeMD. LifeMD is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$212.45M	1.08	-$20.60M	-$0.54	-9.56
The Pennant Group	$695.24M	1.22	$13.38M	$0.70	35.10

Is LFMD or PNTG more profitable?

The Pennant Group has a net margin of 3.24% compared to LifeMD's net margin of -12.06%. The Pennant Group's return on equity of 13.47% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	-12.06%	N/A	-36.34%
The Pennant Group	3.24%	13.47%	3.81%

Which has more volatility & risk, LFMD or PNTG?

LifeMD has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.73, meaning that its share price is 73% more volatile than the S&P 500.

Do analysts rate LFMD or PNTG?

LifeMD presently has a consensus price target of $11.43, suggesting a potential upside of 121.48%. The Pennant Group has a consensus price target of $34.80, suggesting a potential upside of 41.64%. Given LifeMD's stronger consensus rating and higher possible upside, research analysts plainly believe LifeMD is more favorable than The Pennant Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.00
The Pennant Group	0 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.60

Do insiders and institutionals hold more shares of LFMD or PNTG?

35.5% of LifeMD shares are owned by institutional investors. Comparatively, 85.9% of The Pennant Group shares are owned by institutional investors. 16.0% of LifeMD shares are owned by insiders. Comparatively, 5.8% of The Pennant Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Does the media favor LFMD or PNTG?

In the previous week, The Pennant Group had 2 more articles in the media than LifeMD. MarketBeat recorded 7 mentions for The Pennant Group and 5 mentions for LifeMD. LifeMD's average media sentiment score of 0.46 beat The Pennant Group's score of 0.23 indicating that LifeMD is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LifeMD	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
The Pennant Group	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

The Pennant Group beats LifeMD on 12 of the 19 factors compared between the two stocks.